科拓生物,300858,收入构成,报告日期,2020-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他,135,36,98,73.08%,1.4%
动植物微生态制剂,1055,466,589,55.83%,8.41%
食用益生菌制品,1263,344,920,72.81%,13.13%
复配食品添加剂,11561,6161,5401,46.71%,77.06%


